menu search

Why is hoth therapeutics (hoth) stock up 83% today?

Hoth Therapeutics (NASDAQ: HOTH ) stock is rocketing higher on Tuesday thanks to the company announcing positive results from a preclinical trial. Acc...

June 6, 2023, 11:16 am

Inmune bio's alzheimer's treatment merits a high-upside price target, analysts say

Analysts at Baird initiated coverage of the immunology company INmune Bio with a price target more than double its current share price.  The firm iss...

June 2, 2023, 2:26 pm

Medicare unveils plan for coverage of new alzheimer's drugs

Medicare on Thursday announced plans for coverage of new alzheimer's drugs whose accessibility has beco...

June 1, 2023, 1:44 pm

Biogen hits buy zone on a fresh win in alzheimer's disease; eli lilly, eisai shares jump

Biogen stock jumped into a buy zone Thursday after Medicare officials said they would pay for some alzheimer...

June 1, 2023, 12:17 pm

Cassava sciences to present at the jefferies global healthcare conference

AUSTIN, Texas, June 01, 2023 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on ...

June 1, 2023, 9:15 am

Davos alzheimer’s collaborative hosts global meeting on the power of health technology for alzheimer’s

alzheimer’s Experts Share Insights from Deploying alzheimer...

May 31, 2023, 10:13 pm

Cassava (sava) up on progress with alzheimers disease study

Cassava (SAVA) made positive progress with simufilam, an oral drug treatment for alzheimer's disease de...

May 30, 2023, 1:11 pm

1 major advantage biogen may have over pharma giant eli lilly in a multibillion-dollar market

Biogen and Eli Lilly both have promising alzheimer's drugs that have shown they are effective in slowin...

May 19, 2023, 8:15 am

Is a victory for its rivals bad news for axsome therapeutics?

The partnership of Otsuka Pharmaceutical and Lundbeck beat Axsome to market with the first approved treatment for ...

May 17, 2023, 5:30 am

Coya: outstanding data in als and alzheimer's justify large upside

Recently, IPO'd Coya has just reported cognition-improving and cognition-stabilizing results in an open label study in ...

May 16, 2023, 7:17 pm

Biovie aims to treat parkinson's and alzheimer's by focusing on inflammation

By targeting inflammation as a novel pathway, clinical-stage biotechnology company BioVie Inc (NASDAQ:BIVI) aims to discover treatments for neurologic...

May 16, 2023, 8:01 am

Eli lilly's alzheimer's drug is just version 1.0. but it's still on track for blockbuster status, analyst says.

Lilly's alzheimer's treatment could reach blockbuster status by 2025, an analyst said Monday. Eli Lilly...

May 15, 2023, 1:50 pm

These 2 pharma stocks might face off soon -- but they could both win

Two new medicines are going to compete for the alzheimer's therapy market. Eli Lilly's candidate appear...

May 14, 2023, 8:15 am

In one chart: eli lilly on track to close with a higher market cap than j&j for first time since 1997

Eli Lilly’s stock has benefited from positive data in trials of an obesity drug and a treatment for alzheime...

May 12, 2023, 4:55 pm

Here's what eli lilly's latest clinical win means for investors

Eli Lilly's donanemab just proved effective in treating alzheimer's disease in a pivotal clinical trial...

May 12, 2023, 6:20 am

Eli lilly releases positive results on latest disease modifying therapeutic for alzheimer's disease, highlighting need for cognetivity's cognica platform

The news highlights the urgent need for more consistent, wide scale detection of the disease at an early stage Vancouver, British Columbia--(Newsfile ...

May 9, 2023, 9:23 am

Why did eli lilly stock jump 15% in april?

Eli Lilly published positive clinical trial results on a weight-loss drug and an early-stage alzheimer'...

May 8, 2023, 10:56 am

Eli lilly's alzheimer's breakthrough: a game changer for investors and patients

Eli Lilly's donanemab shows promise in slowing alzheimer's progression, offering significant market pot...

May 4, 2023, 10:55 am

Should you buy eli lilly stock now?

Eli Lilly announced the successful results of a phase 3 trial with donanemab, an experimental treatment for al...

May 4, 2023, 5:13 am

Obesity drug could be a 'big upside' for eli lilly, says wells fargo's mohit bansal

Mohit Bansal, Wells Fargo managing director, joins 'Fast Money' to talk Eli Lilly drug trials, it's competition with Biogen for an ...

May 3, 2023, 7:19 pm


Search within

Pages Search Results: